Actively Recruiting

Phase Not Applicable
Age: 5Years - 12Years
All Genders
NCT07092280

Transcranial Direct Current Stimulation in Children With Autism

Led by New York State Institute for Basic Research · Updated on 2026-02-23

24

Participants Needed

1

Research Sites

191 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Although many children diagnosed with autism spectrum disorder (ASD) make significant progress in learning and their cognitive skills improve with applied behavior analysis (ABA), there are a significant number of children who show an absence or a plateau in various skills. Deficits in executive functioning are likely to be involved in many of these cognitive and learning disabilities due to poor functioning of the prefrontal cortex. Currently, the use of biological methods for improving learning and cognition is largely unexplored in research and practice. The aim of this study is to use of transcranial direct current stimulation (tDCS) in combination with ABA to improve the acquisition of educational programs for students with ASD. tDCS is a low-level electrical neurostimulation and is most effective when used in combination with an active training or teaching, facilitating the neuronal circuits used for that task. tDCS has been used for various indications over a couple of decades and has been shown to be very safe and has been well-tolerated by children with ASD. The mechanism of tDCS is not clear, however animal studies show that tDCS can stimulate the flow of calcium ions through channels in the astrocytes, activating them, and facilitating their role in synapse formation and therefore learning.

CONDITIONS

Official Title

Transcranial Direct Current Stimulation in Children With Autism

Who Can Participate

Age: 5Years - 12Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Males and females between 5 and 12 years with autism
  • Enrolled in an ABA program (school or in-home) supervised by a Board Certified Behavior Analyst (BCBA)
  • Stable medical and behavioral treatments for at least 4 weeks prior to, and during the study
  • Able to tolerate wearing tDCS as determined during a week-long daily desensitization training.
Not Eligible

You will not qualify if you...

  • Any implanted metal device (heart pacemaker, cochlear implant, surgical clips, etc.)
  • Severe neurological disorders such as traumatic brain injury, brain tumor, intracranial infection
  • Seizure disorder with a seizure within the last two years
  • Skull defect
  • Peripheral blindness or deafness
  • Taking medications that may affect tDCS, including sodium or calcium channel blockers, NMDA receptor-affecting drugs, serotonin reuptake inhibitors, dopamine agents, norepinephrine agents, seizure-threshold lowering drugs, barbiturates, benzodiazepines, meprobamate, or chloral hydrate within the past 4 weeks
  • Acute skin disease
  • History of magnetic or electrical stimulation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

New York State Institute for Basic Research

Staten Island, New York, United States, 10314

Actively Recruiting

Loading map...

Research Team

J

J. Helen Yoo, Ph.D.

CONTACT

E

Eric London, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here